Mao Jianren
Mol Pain. 2005 Feb 9;1:5. doi: 10.1186/1744-8069-1-5.
Glutamate transporter (GT) plays a major role in the mechanisms of glutamate homeostasis. Can this transporter system be a therapeutic target for glutamate-mediated neurological disorders? In January's edition of Nature, Rothstein et al (2005) reports that the most commonly used class of antibiotics (beta-lactam antibiotics) such as ceftriaxone promoted the expression of GLT1 and demonstrated a functional role in both in vitro and in vivo models of glutamate neurotoxicity. These findings indicate that positive promoters of GT expression may have a unique role in neuroprotection through regulating GT expression. This is also encouraging in search for new pharmacological tools for pain management.
谷氨酸转运体(GT)在谷氨酸稳态机制中起主要作用。这个转运体系统能否成为谷氨酸介导的神经疾病的治疗靶点呢?在1月份的《自然》杂志上,罗斯坦等人(2005年)报道,最常用的一类抗生素(β-内酰胺类抗生素),如头孢曲松,可促进GLT1的表达,并在谷氨酸神经毒性的体外和体内模型中显示出功能作用。这些发现表明,GT表达的正向促进剂可能通过调节GT表达在神经保护中发挥独特作用。这对于寻找疼痛管理的新药理工具也很有鼓舞作用。